Aurora Cannabis has launched four brand new websites to support key European markets, continuing its investment in the region through a more focused, locally-relevant digital presence. The refreshed platforms are designed to better reflect Aurora's science-backed approach, manufacturing expertise, and brand strength, while improving engagement with healthcare professionals, partners, and prospective employees across Europe. The central European site, www.auroramedicine.com, provides easy access to the dedicated regional sites for Germany, the UK, and Poland.
© Aurora Cannabis
"Our new European websites are a demonstration of our ongoing investment and long-term commitment to Aurora's fastest growing region," says Andreas Dotterweich, Senior Vice President, Aurora Europe. "The sites leverage our global leadership in medical cannabis, putting our products, scientific expertise and partnerships front and centre, providing enhanced resources for healthcare practitioners and partners looking for a trusted resource. This streamlined digital presence across Europe positions Aurora to drive growth, reinforce our leadership, and deliver lasting value in Europe."
Building on the recent evolution of Aurora's global brand identity, the new regional websites showcase manufacturing excellence, highlighting both Canadian-made and local production through updated videos and photos while emphasizing quality, compliance, and evidence-based processes. Each platform is available in the native language of its market, and all regional sites are seamlessly accessible from the drop-down menu on the central European hub.
For more information:
Aurora Cannabis Inc.
auroramj.com
